Binah Capital (BCG) Company Overview

Profile

Full Name:

Binah Capital Group, Inc.

Country:

United States

IPO:

March 27, 2024

Indexes:

Not included

Description:

BCG (Binah Capital Group) focuses on investment management and financial services. The company aims to provide innovative solutions for asset management, catering to diverse client needs while emphasizing growth and sustainability in its investment strategies.

Events Calendar

Earnings

Next earnings date:

Feb 28, 2025

Recent quarterly earnings:

Nov 14, 2024

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

No data about analysts updates

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

New Drug Application initiated with U.S. FDA for TAR-200, the first and only intravesical drug releasing system for patients with BCG-unresponsive high-risk non-muscle-invasive bladder cancer
New Drug Application initiated with U.S. FDA for TAR-200, the first and only intravesical drug releasing system for patients with BCG-unresponsive high-risk non-muscle-invasive bladder cancer
New Drug Application initiated with U.S. FDA for TAR-200, the first and only intravesical drug releasing system for patients with BCG-unresponsive high-risk non-muscle-invasive bladder cancer
BCG
prnewswire.comJanuary 15, 2025

Application accepted for U.S. FDA Real-Time Oncology Review (RTOR) based on Phase 2b SunRISe-1 study showing highest single-agent complete response rate of 83.5 percent1 RARITAN, N.J. , Jan. 15, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) announced it has initiated the submission of an original New Drug Application with the U.S. Food and Drug Administration (FDA) for TAR-200 for the treatment of patients with Bacillus Calmette-Guérin (BCG)-unresponsive high-risk non-muscle-invasive bladder cancer (HR-NMIBC) with carcinoma in situ (CIS), with or without papillary tumors.

Binah Capital Group Chief Executive Officer Recognized by the Prestigious InvestmentNews Hot List
Binah Capital Group Chief Executive Officer Recognized by the Prestigious InvestmentNews Hot List
Binah Capital Group Chief Executive Officer Recognized by the Prestigious InvestmentNews Hot List
BCG
globenewswire.comDecember 19, 2024

Craig Gould, CEO of Binah Capital Group (NASDAQ: BCG), has been named to the InvestmentNews Hot List, recognizing his leadership and contributions to the f

1 Stock-Split AI Stock to Buy Before It Soars 450%, According to a Wall Street Expert
1 Stock-Split AI Stock to Buy Before It Soars 450%, According to a Wall Street Expert
1 Stock-Split AI Stock to Buy Before It Soars 450%, According to a Wall Street Expert
BCG
fool.comDecember 8, 2024

Philip Panaro is a founder and former CEO of Boston Consulting Group (BCG) Platinion, a division of BCG that offers technology consulting services. During an interview in November, Panaro told Schwab Network that Nvidia (NVDA -1.81%) could hit $800 per share by 2030 due to its leadership in artificial intelligence (AI) accelerators.

Groundbreaking Cretostimogene Grenadenorepvec Monotherapy Data Demonstrates Sustained, Durable Complete Responses in High-Risk BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Groundbreaking Cretostimogene Grenadenorepvec Monotherapy Data Demonstrates Sustained, Durable Complete Responses in High-Risk BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Groundbreaking Cretostimogene Grenadenorepvec Monotherapy Data Demonstrates Sustained, Durable Complete Responses in High-Risk BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
BCG
globenewswire.comDecember 5, 2024

Groundbreaking Cretostimogene Grenadenorepvec Monotherapy Data Demonstrates Sustained, Durable Complete Responses in High-Risk BCG-Unresponsive Non-Muscle

PKS Investments, a Subsidiary of Binah Capital Group, Recognized as One of Albany's Best Places to Work
PKS Investments, a Subsidiary of Binah Capital Group, Recognized as One of Albany's Best Places to Work
PKS Investments, a Subsidiary of Binah Capital Group, Recognized as One of Albany's Best Places to Work
BCG
globenewswire.comOctober 16, 2024

ALBANY, N.Y., Oct. 16, 2024 (GLOBE NEWSWIRE) -- Binah Capital Group (NASDAQ: BCG) (“Binah” or the “Company”) is proud to announce that its subsidiary, PKS Investments (“PKS”), has been recognized as one of Albany's Best Places to Work for by the Albany Business Review. This prestigious award places PKS Investments among the top large companies (100+ employees) in the Albany area for employee satisfaction and workplace culture.

FAQ

  • What is the ticker symbol for Binah Capital?
  • Does Binah Capital pay dividends?
  • What sector is Binah Capital in?
  • What industry is Binah Capital in?
  • What country is Binah Capital based in?
  • When did Binah Capital go public?
  • Is Binah Capital in the S&P 500?
  • Is Binah Capital in the NASDAQ 100?
  • Is Binah Capital in the Dow Jones?
  • When was Binah Capital's last earnings report?
  • When does Binah Capital report earnings?

What is the ticker symbol for Binah Capital?

The ticker symbol for Binah Capital is NASDAQ:BCG

Does Binah Capital pay dividends?

No, Binah Capital does not pay dividends

What sector is Binah Capital in?

Binah Capital is in the Financial Services sector

What industry is Binah Capital in?

Binah Capital is in the Asset Management industry

What country is Binah Capital based in?

Binah Capital is headquartered in United States

When did Binah Capital go public?

Binah Capital's initial public offering (IPO) was on March 27, 2024

Is Binah Capital in the S&P 500?

No, Binah Capital is not included in the S&P 500 index

Is Binah Capital in the NASDAQ 100?

No, Binah Capital is not included in the NASDAQ 100 index

Is Binah Capital in the Dow Jones?

No, Binah Capital is not included in the Dow Jones index

When was Binah Capital's last earnings report?

Binah Capital's most recent earnings report was on Nov 14, 2024

When does Binah Capital report earnings?

The next expected earnings date for Binah Capital is Feb 28, 2025